Table of Contents
ISRN Allergy
Volume 2011 (2011), Article ID 295124, 4 pages
http://dx.doi.org/10.5402/2011/295124
Clinical Study

Serum Fructosamine, Total Cholesterol, and High-Density Lipoprotein in Children with Asthma during Glucocorticoid Treatment

Children's Clinic Randers, Dytmaersken 9, 8900 Randers C, Denmark

Received 14 May 2011; Accepted 3 July 2011

Academic Editors: D. Bergren and A. Lorentz

Copyright © 2011 A. J. Schou and O. D. Wolthers. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. T. C. Yao, L. S. Ou, K. W. Yeh, W. I. Lee, L. C. Chen, and J. L. Huang, “Associations of age, gender, and BMI with prevalence of allergic diseases in children,” Journal of Asthma, vol. 48, no. 5, pp. 503–510, 2011. View at Publisher · View at Google Scholar · View at PubMed
  2. GINA Report, “Global Strategy for Asthma Management and Prevention,” 2010, http://www.ginasthma.org/guidelines-gina-report-global-strategy-for-asthma.html.
  3. D. Keeley, “Parent-initiated treatment with prednisolone can reduce symptoms for children with acute asthma exacerbations,” Journal of Pediatrics, vol. 157, no. 3, p. 515, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  4. O. D. Wolthers, “Impact of inhaled and intranasal corticosteroids on the growth of children,” BioDrugs, vol. 13, no. 5, pp. 347–357, 2000. View at Google Scholar · View at Scopus
  5. H. W. Kelly, “Potential adverse effects of the inhaled corticosteroids,” Journal of Allergy and Clinical Immunology, vol. 112, no. 3, pp. 469–478, 2003. View at Publisher · View at Google Scholar · View at Scopus
  6. O. D. Wolthers, “Methodology and implications of knemometry in growth assessment of inhaled glucocorticoids,” Pediatric Allergy and Immunology, vol. 21, no. 1, part 2, pp. e190–e198, 2010. View at Publisher · View at Google Scholar · View at PubMed
  7. R. C. Andrews and B. R. Walker, “Glucocorticoids and insulin resistance: old hormones, new targets,” Clinical Science, vol. 96, no. 5, pp. 513–523, 1999. View at Publisher · View at Google Scholar · View at Scopus
  8. J. A. Yanovski and G. B. Cutler Jr., “Glucocorticoid action and the clinical features of Cushing's syndrome,” Endocrinology and Metabolism Clinics of North America, vol. 23, no. 3, pp. 487–509, 1994. View at Google Scholar · View at Scopus
  9. P. Bjorntorp, “Hormonal control of regional fat distribution,” Human Reproduction, vol. 12, supplement 1, pp. 21–25, 1997. View at Google Scholar
  10. Y. T. Kruszynska, M. Greenstone, P. D. Home, and N. J. Cooke, “Effect of high dose inhaled beclomethasone dipropionate on carbohydrate and lipid metabolism in normal subjects,” Thorax, vol. 42, no. 11, pp. 881–884, 1987. View at Google Scholar · View at Scopus
  11. K. Kiviranta and M. Turpeinen, “Effect of eight months of inhaled beclomethasone dipropionate and budesonide on carbohydrate metabolism in adults with asthma,” Thorax, vol. 48, no. 10, pp. 974–978, 1993. View at Google Scholar · View at Scopus
  12. P. Ebden, P. McNally, A. Samanta, and G. J. Fancourt, “The effects of high dose inhaled beclomethasone dipropionate on glucose and lipid profiles in normal and diet controlled diabetic subjects,” Respiratory Medicine, vol. 83, no. 4, pp. 289–291, 1989. View at Google Scholar · View at Scopus
  13. M. Turpeinen, R. Sorva, and K. Juntunen-Backman, “Changes in carbohydrate and lipid metabolism in children with asthma inhaling budesonide,” Journal of Allergy and Clinical Immunology, vol. 88, no. 3, part 1, pp. 384–389, 1991. View at Google Scholar · View at Scopus
  14. D. A. Armbruster, “Fructosamine: structure, analysis, and clinical usefulness,” Clinical Chemistry, vol. 33, no. 12, pp. 2153–2163, 1987. View at Google Scholar · View at Scopus
  15. A. J. Schou, “Knemometry for assessment of growth suppressive effects of exogenous glucocorticoids,” Current Pediatric Reviews, vol. 2, no. 1, pp. 77–83, 2006. View at Google Scholar · View at Scopus
  16. O. D. Wolthers and S. Pedersen, “Growth of asthmatic children during treatment with budesonide: a double blind trial,” British Medical Journal, vol. 303, no. 6795, pp. 163–165, 1991. View at Google Scholar · View at Scopus
  17. C. Heuck, L. Heickendorff, and O. D. Wolthers, “A randomised controlled trial of short term growth and collagen turnover in asthmatics treated with inhaled formoterol and budesonide,” Archives of Disease in Childhood, vol. 83, no. 4, pp. 334–339, 2000. View at Publisher · View at Google Scholar · View at Scopus
  18. M. Hills and P. Armitage, “The two-period cross-over clinical trial,” British Journal of Clinical Pharmacology, vol. 8, no. 1, pp. 7–20, 1979. View at Google Scholar · View at Scopus
  19. J. J. Gagliardino, “Physiological endocrine control of energy homeostasis and postprandial blood glucose levels,” European Review for Medical and Pharmacological Sciences, vol. 9, no. 2, pp. 75–92, 2005. View at Google Scholar · View at Scopus
  20. D. Czock, F. Keller, F. M. Rasche, and U. Haussler, “Pharmacokinetics and pharmacodynamics of systemically administered glucocorticoids,” Clinical Pharmacokinetics, vol. 44, no. 1, pp. 61–98, 2005. View at Publisher · View at Google Scholar · View at Scopus
  21. A. R. Boobis, “Comparative physicochemical and pharmacokinetic profiles of inhaled beclomethasone dipropionate and budesonide,” Respiratory Medicine, vol. 92, supplement B, pp. 2–6, 1998. View at Google Scholar · View at Scopus
  22. S. Pedersen and P. O'Byrne, “A comparison of the efficacy and safety of inhaled corticosteroids in asthma,” Allergy:, vol. 52, no. 39, supplement, pp. 1–34, 1997. View at Google Scholar · View at Scopus
  23. K. Maedler and M. Y. Donath, “Beta-cells in type 2 diabetes: a loss of function and mass,” Hormone Research, vol. 62, supplement 3, pp. 67–73, 2004. View at Google Scholar · View at Scopus
  24. J. R. Mead, S. A. Irvine, and D. P. Ramji, “Lipoprotein lipase: Structure, function, regulation, and role in disease,” Journal of Molecular Medicine, vol. 80, no. 12, pp. 753–769, 2002. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus